Literature DB >> 8855680

Pediatric hospital admissions for measles. Lessons from the 1990 epidemic.

G F Chavez1, A A Ellis.   

Abstract

To examine the descriptive epidemiology of serious measles complications and associated hospital costs during a major epidemic, we used California population-based hospital discharge data to identify hospital admissions for measles during 1986 through 1990 (ICD-9 code 055, n = 4,201). We examined 5-year trends and, for 1990 pediatric epidemic cases (n = 2,234), sociodemographic and hospital admission financial data. Hospital admission rates for measles rose significantly between 1986 and 1990. During the 1990 epidemic, preschool children aged 1 to 5 years, Medi-Cal (California's Medicaid) beneficiaries, Hispanics, and those living in urban counties accounted for most hospital admissions. Young infants and residents of southern California and the San Joaquin Valley had the highest risks. Medi-Cal beneficiaries and Asian children were at an increased risk for death during the hospital stay. The average hospital admission cost was $8,201, and the average length of hospital stay was 4.6 days. Hospital costs amounted to $18 million, two thirds of which was paid for by Medi-Cal. Measles is a serious disease that can result in severe complications requiring lengthy and costly hospital stays. We must remain alert to its continuing threat, complications, and resulting financial burdens.

Entities:  

Mesh:

Year:  1996        PMID: 8855680      PMCID: PMC1307536     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  11 in total

Review 1.  Epidemiology of measles in the United States in 1989 and 1990.

Authors:  J S Gindler; W L Atkinson; L E Markowitz; S S Hutchins
Journal:  Pediatr Infect Dis J       Date:  1992-10       Impact factor: 2.129

2.  Measles surveillance--United States, 1991.

Authors:  W L Atkinson; S C Hadler; S B Redd; W A Orenstein
Journal:  MMWR CDC Surveill Summ       Date:  1992-11-20

Review 3.  Monitoring progress toward US preschool immunization goals.

Authors:  F T Cutts; E R Zell; D Mason; R H Bernier; E F Dini; W A Orenstein
Journal:  JAMA       Date:  1992-04-08       Impact factor: 56.272

4.  Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic.

Authors:  K M Farizo; P A Stehr-Green; L E Markowitz; P A Patriarca
Journal:  Pediatrics       Date:  1992-04       Impact factor: 7.124

Review 5.  The resurgence of measles in the United States, 1989-1990.

Authors:  W L Atkinson; W A Orenstein; S Krugman
Journal:  Annu Rev Med       Date:  1992       Impact factor: 13.739

Review 6.  A new look at measles.

Authors:  L M Adcock; J D Bissey; R D Feigin
Journal:  Infect Dis Clin North Am       Date:  1992-03       Impact factor: 5.982

7.  Clinical efficacy of measles vaccine during the 1990 measles epidemic.

Authors:  G E King; L E Markowitz; P A Patriarca; L G Dales
Journal:  Pediatr Infect Dis J       Date:  1991-12       Impact factor: 2.129

8.  Measles vaccination coverage among Latino children aged 12 to 59 months in Los Angeles County: a household survey.

Authors:  D P Ewert; J C Thomas; L Y Chun; R C Enguidanos; S H Waterman
Journal:  Am J Public Health       Date:  1991-08       Impact factor: 9.308

9.  Measles vaccination levels among selected groups of preschool-aged children--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-01-18       Impact factor: 17.586

10.  Prevalence of measles susceptibility in hospital staff. Evidence to support expanding the recommendations of the Immunization Practices Advisory Committee.

Authors:  S Schwarcz; B McCaw; P Fukushima
Journal:  Arch Intern Med       Date:  1992-07
View more
  3 in total

1.  California's 1988-1991 measles epidemic--the last one?

Authors:  N J Smith; L G Dales; S H Waterman
Journal:  West J Med       Date:  1996 Jul-Aug

Review 2.  Latino child health: need for inclusion in the US national discourse.

Authors:  R E Zambrana; L A Logie
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

3.  The average cost of measles cases and adverse events following vaccination in industrialised countries.

Authors:  Hélène Carabin; W John Edmunds; Ulla Kou; Susan van den Hof; Van Hung Nguyen
Journal:  BMC Public Health       Date:  2002-09-19       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.